Coronavirus Disease 2019 (COVID-19) Company Impact - Moderna Inc

Coronavirus Disease 2019 (COVID-19) Company Impact - Moderna Inc

  • June 2020 •
  • 30 pages •
  • Report ID: 5916113 •
  • Format: PDF
Coronavirus Disease 2019 (COVID-19) Company Impact - Moderna Inc

Summary
This report gives an important expert analysis on how COVID-19 will affect Moderna Incorporated. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.

Scope
- The coronavirus (COVID-19) company impact report analyses how the pandemic will impact Moderna Inc. performance.
- Moderna is a pipeline biotech company
- Moderna’s focus is on mRNA-based prophylactic and therapeutic vaccines
- Moderna’s pipeline is most active in early stages of drug development
- mRNA-1273 is Moderna’s main weapon against COVID-19

Reasons to Buy
- An overview of how Moderna Inc. will be affected by the COVID-19 pandemic.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.